SCHEMBL3302887

SCHEMBL3302887

CCCCCCn1ccnn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 1/20 0.46
TLR8 Q9NR97 2/20 0.39
SLC9A1 P19634 3/20 0.39
SMPD1 P17405 4/20 0.38
CYP19A1 P11511 2/20 0.38
NPC1 O15118 5/20 0.36
RAB9A P51151 5/20 0.36
HTT P42858 4/20 0.36
GALR3 O60755 2/20 0.36
POLB P06746 2/20 0.36
ATM Q13315 2/20 0.36
MAPK1 P28482 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPT P10636 1/20 0.36
RAD52 P43351 1/20 0.36
PAX8 Q06710 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11204798 1.00 TBXAS1 (0.46) TBXAS1TLR8SLC9A1SMPD1CYP19A1
SCHEMBL243704 1.00 TBXAS1 (0.46) TBXAS1TLR8SLC9A1SMPD1CYP19A1
SCHEMBL245885 1.00 TBXAS1 (0.46) TBXAS1TLR8SLC9A1SMPD1CYP19A1
SCHEMBL21925549 1.00 TBXAS1 (0.46) TBXAS1TLR8SLC9A1SMPD1CYP19A1
SCHEMBL245126 1.00 TBXAS1 (0.46) TBXAS1TLR8SLC9A1SMPD1CYP19A1
SCHEMBL20204363 1.00 TBXAS1 (0.46) TBXAS1TLR8SLC9A1SMPD1CYP19A1
SCHEMBL628307 0.98 TBXAS1 (0.42) TBXAS1TLR8SLC9A1SMPD1CYP19A1
SCHEMBL9634208 0.89 MGLL (0.45) TBXAS1
Sulfuric Acid SCHEMBL16340543 0.87 ALDH1A1 (0.38) TBXAS1TLR8SLC9A1SMPD1CYP19A1
SCHEMBL18723226 0.86 TBXAS1 (0.35) TBXAS1TLR8SLC9A1SMPD1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240231230-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM NISSAN CHEMICAL CORPORATION (JP) 2024-07-11 US disclosed
CN-116472273-A Antidiabetic compounds and compositions 宁康瑞珠生物制药(珠海)有限公司 2023-07-21 CN disclosed
US-11407732-B1 Tricyclic degraders of Ikaros and Aiolos C4 THERAPEUTICS, INC. (US) 2022-08-09 US disclosed
WO-2022028317-A1 ANTIDIABETIC COMPOUNDS AND COMPOSITIONS REZUBIO PHARMACEUTICALS CO., LTD (CN) 2022-02-10 WO disclosed
CN-108931525-B Rapid identification of brake fluid 通用汽车环球科技运作有限责任公司 2021-02-09 CN disclosed
US-10461266-B2 Luminescent compounds and methods of using same QUEEN'S UNIVERSITY AT KINGSTON (CA) 2019-10-29 US disclosed
US-20170358761-A1 Luminescent Compounds and Methods of Using Same QUEEN'S UNIVERSITY AT KINGSTON (CA) 2017-12-14 US disclosed
EP-2958181-B1 NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEM CORP (JP) 2017-06-14 EP disclosed
US-9653754-B2 Nonaqueous electrolytes and nonaqueous-electrolyte secondary batteries employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2017-05-16 US disclosed
CN-104167564-B Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery 三菱化学株式会社 2017-04-12 CN disclosed
US-20120308881-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQEUOUS-ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2012-12-06 US disclosed
US-20120264010-A1 NONAQUEOUS ELECTROLYTES AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERIES EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2012-10-18 US disclosed
US-20100099031-A1 NONAQUEOUS ELECTROLYTES AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERIES EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2010-04-22 US disclosed
EP-2166611-A1 NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH THE NONAQUEOUS ELECTROLYTE Mitsubishi Chemical Corporation (JP) 2010-03-24 EP disclosed
CN-101663790-A Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same MITSUBISHI CHEM CORP 2010-03-03 CN disclosed
US-5100890-A Antidepressants, Fungicides HOECHST AKTIENGESELLSCHAFT (DE) 1992-03-31 US disclosed
US-5023357-A Arylmethylazole preparation processes HOECHST AKTIENGESELLSCHAFT (DE) 1991-06-11 US disclosed
US-4876354-A FUNGICIDES, ANTIDEPRESSANTS HOECHST AKTIENGESELLSCHAFT (DE) 1989-10-24 US disclosed
US-4375420-A Selected 4-hydroxyphenyl anilino alkoxysilanes and their use as antioxidants OLIN CORPORATION (US) 1983-03-01 US disclosed
US-4234441-A Silicone oil compositions containing silicate cluster compounds OLIN CORPORATION (US) 1980-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170358761-A1 Luminescent Compounds and Methods of Using Same CRY2, CYBA, TYR TBXAS1 773/4885TLR8 4792/4885SLC9A1 1556/4885
US-11407732-B1 Tricyclic degraders of Ikaros and Aiolos CRBN, IKZF1, IKZF3 TBXAS1 2916/4885TLR8 2931/4885SLC9A1 4881/4885
US-10461266-B2 Luminescent compounds and methods of using same CRY2, CYBA, TYR TBXAS1 773/4885TLR8 4792/4885SLC9A1 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.